4P-Pharma is delighted to welcome Mathilde Mérot appointed Director of Regulatory Affairs and Clinical Operations. She has ten years of experience and a background in Pharma and Biotech companies. Her expertise will complement ours to develop and bring curative therapies for serious untreated diseases to patients. About Mathilde Mérot Mathilde Mérot started her career in clinical&hellip
We are delighted to announce the appointment of Didier Landais as the CEO of 4P-Pharma. Didier Landais brings a wealth of experience and strategic leadership to our team. His dynamic vision and profound insights will drive 4P-Pharma into an era of innovation and growth. Find the press release in English here.